Bristol Will Use One Distributor To Ensure Patient Access For Orencia Launch

Bristol-Myers Squibb is launching its rheumatoid arthritis treatment Orencia (abatacept) through a sole distributor to ensure patient access while the firm works to expand its manufacturing capacity